Topical ivermectin lotion 0.5% (Sklice, and generics), which has been available by prescription since 2012, is now FDA-approved for sale over the counter (OTC) for treatment of head lice in patients ≥6…
Med Lett Drugs Ther. 2023 Jun 26; 65(1679):103-4 doi:10.58347/tml.2023.1679e
Topical ivermectin lotion 0.5% (Sklice, and generics), which has been available by prescription since 2012, is now FDA-approved for sale over the counter (OTC) for treatment of head lice in patients ≥6 months old. Ivermectin is also available by prescription as a 1% cream (Soolantra) approved for topical treatment of inflammatory lesions of rosacea and in oral tablets ( Stromectol , and generics) for treatment of various parasitic infections.
Head lice infestation occurs in all age groups, but especially in elementary school children. In most cases, transmission occurs by head-to-head contact.
Med Lett Drugs Ther. 2016 Nov 21; 58(1508):150-2
Head lice infestation occurs in all age groups, but especially in elementary school children. In most cases, transmission occurs by head-to-head contact.
The FDA has approved the antiparasitic drug ivermectin in a 0.5% lotion ( Sklice – Sanofi Pasteur) as a single-use topical treatment for head lice in patients ≥6 months old. Oral ivermectin ( Stromectol…
Med Lett Drugs Ther. 2012 Aug 6; 54(1396):61-3
The FDA has approved the antiparasitic drug ivermectin in a 0.5% lotion ( Sklice – Sanofi Pasteur) as a single-use topical treatment for head lice in patients ≥6 months old. Oral ivermectin ( Stromectol – Merck) is effective for treatment of head lice resistant to other therapies, but it has not been approved by the FDA for this indication.
The FDA has approved spinosad 0.9% suspension ( Natroba – ParaPro) for topical treatment of head lice infestation in patients ≥4 years old. It is available only by prescription.
Med Lett Drugs Ther. 2011 Jun 27; 53(1367):50-1
The FDA has approved spinosad 0.9% suspension ( Natroba – ParaPro) for topical treatment of head lice infestation in patients ≥4 years old. It is available only by prescription.
The FDA has approved benzyl alcohol lotion, 5% ( Ulesfia Lotion - Sciele) for treatment of head lice in patients ≥6 months old. The active ingredient is 5% benzyl alcohol; the vehicle is 5% mineral oil.
Med Lett Drugs Ther. 2009 Jul 27; 51(1317):57-8
The FDA has approved benzyl alcohol lotion, 5% ( Ulesfia Lotion - Sciele) for treatment of head lice in patients ≥6 months old. The active ingredient is 5% benzyl alcohol; the vehicle is 5% mineral oil.